Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: A phase II randomized selection trial

Binghe Xu, Zefei Jiang, Sung Bae Kim, Shiying Yu, Jifeng Feng, Artur Malzyner, Auro Del Giglio, Hyun C. Chung, Li Jun Shen, Daniel Lee Kay Pen

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: A phase II randomized selection trial'. Together they form a unique fingerprint.

Medicine & Life Sciences